Nutrient loss pathways from grazed grasslands and the effects of decreasing inputs: experimental results for three soil types

Agriculture is a main contributor of diffuse emissions of N and P to the environment. For N the main loss pathways are NH3-volatilization, leaching to ground and surface water and N-2(O) emissions. Currently, imposing restraints on farm inputs are used as policy tool to decrease N and P leaching to ground water and to surface water, and the same measure is suggested to combat emissions of N2O. The response, however, to these measures largely depends on the soil type. In this study nutrient flows of three dairy farms in The Netherlands with comparable intensity on sand, peat and clay soils were monitored for at least 2 years. The first aim was to provide quantitative data on current nutrient loss pathways. The second aim was to explore the responses in partitioning of the nutrient loss pathways when farm inputs were altered. Mean denitrification rates ranged from 103 kg N ha(-1) year(-1) for the sandy soil to 170 kg N ha(-1) year(-1) for the peat soil and leaching to surface water was about 73 kg N ha(-1) year(-1) for the sandy soil, 15 kg N ha(-1) year(-1) for the clay soil and 38 kg N ha(-1) year(-1) for the peat soil. For P, leaching to surface water ranged from 2 kg P ha(-1) year(-1) for the sandy site to 5 kg P ha(-1) year(-1) for the peat site. The sandy soil was most responsive to changes in N surpluses on leaching to surface water, followed by the peat soil and least responsive was the clay soil. For P, a similar sequence was found. This article demonstrates that similar reductions of N and P inputs result in different responses in N and P loss pathways for different soil types. These differences should be taken into account when evaluating measures to improve environmental performance of (dairy) farm

Fluvial incision into bedrock: Insights from morphometric analysis and numerical modeling of gorges incising glacial hanging valleys (Western Alps, France)

International audienceBedrock gorges incising glacial hanging valleys potentially allow measurements of fluvial bedrock incision in mountainous relief. Using digital elevation models, topographic maps, and field reconnaissance, we identified and characterized 30 tributary hanging valleys incised by gorges near their confluence with trunk streams in the Romanche watershed, French Western Alps. Longitudinal profiles of these tributaries are all convex and have abrupt knickpoints at the upper limit of oversteepened gorge reaches. We reconstructed initial glacial profiles from glacially polished bedrock knobs surrounding the gorges in order to quantify the amount of fluvial incision and knickpoint retreat. From morphometric analyses, we find that mean channel gradients and widths, as well as knickpoint retreat rates, display a drainage area dependence modulated by bedrock lithology. However, there appears to be no relation between horizontal retreat and vertical downwearing of knickpoints. Assuming a postglacial origin of these gorges, our results imply high postglacial fluvial incision (0.5-15 mm yr−1) and knickpoint retreat (1-200 mm yr−1) rates that are, however, consistent with previous estimates. Numerical modeling was used to test the capacity of different fluvial incision models to predict the inferred evolution of the gorges. Results from simple end‐member models suggest transport‐limited behavior of the bedrock gorges. A more sophisticated model including dynamic width adjustment and sediment‐dependent incision rates predicts present‐day channel geometry only if a significant supply of sediment from the gorge sidewalls (∼10 mm yr−1) is triggered by gorge deepening, combined with pronounced inhibition of bedrock incision by sediment transport and deposition

Recent developments in the rapid analysis of plants and tracking their bioactive constituents

Natural products chemistry has witnessed many new developments in the last 5 years like extractions with subcritical water and ionic liquids, LC/HRMS and LC/SPE/cryo-NMR, UHPLC, TLC/MS, MS-based preparative HPLC, comprehensive chromatography (GC × GC, LC × LC), high-throughput screening, introduction of monolithic columns, miniaturisation, and automated structure identification. Nevertheless identifying bioactive constituents in complex plant extracts remains a tedious process. The classical approach of bioassay guided fractionation is time-consuming while off-line screening of extracts does not provide information on individual compounds and sometimes suffers from false positives or negatives. One way out of this is by coupling chromatography with chemical or biochemical assays, so called high resolution screening. An example is the development of HPLC on-line assays for antioxidants. By the post-column addition of a relatively stable coloured radical like DPPH¿ or ABTS¿+, radical scavengers are detected as negative peaks because in a reaction coil they reduce the model radical to its reduced, non-coloured form. When combined with LC/DAD/MS and LC/SPE/NMR, reliable identification of active constituents becomes possible without the necessity of ever isolating them in a classical sense. Also for finding leads for new drugs, combining HPLC with biochemical assays is interesting but technically more difficult. Most enzymes do not work at the organic modifier concentrations commonly encountered in RP-HPLC and the reaction time is often longer requiring dilution and lengthy coils respectively. Therefore, new techniques have to be implemented to gain the required sensitivity for on-line enzyme assays. For stable analytes, high temperature LC offers a solution to the organic modifier problem. When enzymes are highly expensive, like those used in the screening for Cytochrome P450 inhibitors, miniaturisation to chip format may offer a way out. Microreactors (chips) are not only useful for miniaturising larger assays but also offer completely new prospects in phytochemical analysis. One such application is in the sample clean-up of acids and bases like alkaloids. In a lay-out of three parallel channels of 100 ¿m width with the middle one containing organic phase and the two outer ones water of high pH (feed phase) and low pH (trapping phase) such a chip replaces two classical LLE steps but is much faster and requires less solvents and less manpower input

Kidney and heart failure outcomes associated with SGLT2 inhibitor use

Chronic kidney disease (CKD) and heart failure affect many people worldwide. Despite the availability of pharmacological treatments, both diseases remain associated with considerable morbidity and mortality. After observations that sodium-glucose co-transporter 2 (SGLT2) inhibitors - originally developed as glucose-lowering agents - improved cardiovascular and renal outcomes in patients with type 2 diabetes, dedicated trials were initiated to evaluate the cardiovascular and kidney protective effects in patients with CKD or heart failure. The results of these clinical trials and subsequent detailed analyses have shown that the benefits of SGLT2 inhibitors are consistent across many patient subgroups, including those with and without type 2 diabetes, at different stages of CKD, and in patients with heart failure with preserved or reduced ejection fraction. In addition, post-hoc analyses revealed that SGLT2 inhibitors reduce the risk of anaemia and hyperkalaemia in patients with CKD. With respect to their safety, SGLT2 inhibitors are generally well tolerated. More specifically, no increased risk of hypoglycaemia has been observed in patients with CKD or heart failure without diabetes and they do not increase the risk of acute kidney injury. SGLT2 inhibitors therefore provide clinicians with an exciting new treatment option for patients with CKD and heart failure. Clinical trials have demonstrated sodium-glucose co-transporter 2 (SGLT2) inhibitors to be safe and effective drugs that improve kidney outcomes in patients with and without diabetes. SGLT2 inhibitors also improve heart failure outcomes for patients with preserved or reduced ejection fraction. This Review summarizes findings from clinical trials of SGLT2 inhibitors, focusing on the effects of these agents in patients with chronic kidney disease and heart failure, and describes how potential mechanisms of action may translate into clinical benefit

Simple, fast and robust LC-MS/MS method for the simultaneous quantification of canagliflozin, dapagliflozin and empagliflozin in human plasma and urine

Sodium–glucose cotransporter 2 –inhibitors (SGLT2i) are oral glucose-lowering drugs that have also demonstrated cardioprotective and renoprotective effects. SGLT2i play an increasingly important role in the treatment of type 2 diabetes. Here we report a simple and robust liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the simultaneous quantification of three SGLT2i (canagliflozin, dapagliflozin and empagliflozin) in human plasma, serum and urine with a runtime of 1 min. Methanol was used as protein precipitating agent. Chromatographic separation was accomplished using a Waters ACQUITY UPLC HSS T3 1.8 μm; 2.1 × 50 mm column with a Waters ACQUITY UPLC HSS T3 1.8 μm VanGuard Pre-column; 2.1 × 5 mm, using gradient elution with ammonium acetate 20 mM (pH 5) and acetonitrile as mobile phase at a flow rate of 0.8 ml/min. Mass spectrometric analysis of the acetate adduct ions was carried out using electrospray with negative ionization and SRM mode. The assay was validated according to FDA and EMA guidelines, including selectivity, linearity, accuracy and precision, dilution integrity, stability and recovery. With a sample volume of 200 µl, linear ranges of 10–5000 µg/L, 1–500 µg/L and 2–1000 µg/L for canagliflozin, dapagliflozin and empagliflozin respectively, were achieved. The assay was successfully applied in two pharmacokinetic studies with dapagliflozin and empagliflozin. In conclusion, we developed and validated a simple, fast and robust LC-MS/MS method for the simultaneous quantification of canagliflozin, dapagliflozin and empagliflozin, that allows rapid analysis of large numbers of samples and can be used for both pharmacokinetic studies and biomedical analysis of canagliflozin, dapagliflozin and empagliflozin

Vortex Solid-Liquid Transition in Bi2_{2}Sr2_{2}CaCu2_{2}O8+δ_{8+\delta} with a High Density of Strong Pins

The introduction of a large density of columnar defects in %underdoped Bi$_{2}$Sr$_{2}$CaCu$_{2}$O$_{8+\delta}$ crystals does not, at sufficiently low vortex densities, increase the irreversibility line beyond the first order transition (FOT) field of pristine crystals. At such low fields, the flux line wandering length $r_{w}$ behaves as in pristine %Bi$_{2}$Sr$_{2}$CaCu$_{2}$O$_{8+\delta}$ crystals. Next, vortex positional correlations along the $c$--axis in the vortex Bose glass at fields above the FOT are smaller than in the low--field vortex solid. Third, the Bose-glass-to-vortex liquid transition is signaled by a rapid decrease in c-axis phase correlations. These observations are understood in terms of the ``discrete superconductor'' model.Comment: 4 pages, 4 figures Submitted to Phys. Rev. B Rapid Comm. 16-1-2004 Revised version 18-3-200

Defect-unbinding and the Bose-glass transition in layered superconductors

The low-field Bose-glass transition temperature in heavy-ion irradiated Bi_2Sr_2CaCu_2O_8+d increases progressively with increasing density of irradiation-induced columnar defects, but saturates for densities in excess of 1.5 x10^9 cm^-2. The maximum Bose-glass temperature corresponds to that above which diffusion of two-dimensional pancake vortices between different vortex lines becomes possible, and above which the ``line-like'' character of vortices is lost. We develop a description of the Bose-glass line that is in excellent quantitative agreement with the experimental line obtained for widely different values of track density and material parameters.Comment: 4 pages, 4 figures, submitted to Phys. Rev. Let